← FDA Drug Approvals (Drugs@FDA)
OXALIPLATIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA WORLDWIDE · Approved 2009-08-07
Drug application
- FDA Application #
ANDA078813- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXALIPLATIN
- Generic name
- OXALIPLATIN
- Active ingredients
- OXALIPLATIN
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- HOSPIRA WORLDWIDE
- Manufacturer
- Hospira, Inc.
- First approval
- 2009-08-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown